CN Patent

CN119613233A — 一种共晶化合物、其制备方法和应用

Assigned to Shanghai Syncores Technologies Inc ltd · Expires 2025-03-14 · 1y expired

What this patent protects

本发明提供了一种4‑溴‑2‑异丙基苯酚4‑二甲氨基吡啶共晶化合物及其制备方法，以及将该共晶化合物用于制备吉法匹生或其盐的方法。本发明提供的方法收率高，原料价格便宜、且中间体易分离，操作简单，非常适合工业化生产。

USPTO Abstract

本发明提供了一种4‑溴‑2‑异丙基苯酚4‑二甲氨基吡啶共晶化合物及其制备方法，以及将该共晶化合物用于制备吉法匹生或其盐的方法。本发明提供的方法收率高，原料价格便宜、且中间体易分离，操作简单，非常适合工业化生产。

Drugs covered by this patent

indigotindisulfonate-sodium (INDIGOTINDISULFONATE SODIUM)

Patent Metadata

Patent number: CN119613233A
Jurisdiction: CN
Classification: —
Expires: 2025-03-14
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Syncores Technologies Inc ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.